Company Filing History:
Years Active: 2004
Title: Innovations of Inventor Ning Hu
Introduction
Ning Hu is an accomplished inventor based in San Gabriel, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of two patents to his name, Ning Hu is recognized for his work in enhancing the efficacy of anti-tumor agents.
Latest Patents
Ning Hu's latest patents include liposomal camptothecin formulations and liposomal benzoquinazoline thymidylate synthase inhibitor formulations. The liposomal camptothecin formulations provide improved pharmacokinetics and enhanced efficacy as anti-tumor agents. These formulations utilize liposomes that comprise at least one phospholipid and a camptothecin or its analog. The second patent, focusing on liposomal benzoquinazoline thymidylate synthase inhibitor formulations, also demonstrates improved pharmacokinetics and efficacy compared to the free drug. These formulations include liposomes made up of at least one phosphatidylcholine, cholesterol, and a benzoquinazoline thymidylate synthase inhibitor.
Career Highlights
Ning Hu is currently employed at Osi Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is pivotal in developing formulations that enhance the therapeutic index of cancer treatments.
Collaborations
Ning Hu collaborates with notable colleagues, including David Lloyd Emerson and Su-Ming Chiang, who contribute to his research and development efforts.
Conclusion
Ning Hu's contributions to pharmaceutical innovations, particularly in anti-tumor formulations, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in cancer treatment.